Jerusalem, 10 February, 2026 (TPS-IL) — Israeli computational chemistry company Evogene Ltd. is expanding its collaboration with Google Cloud to integrate advanced AI agents into its ChemPass AI platform. Based in Rehovot, Evogene develops AI-driven small-molecule design for pharmaceuticals and Agriculture.
The new phase aims to automate complex discovery workflows, accelerate molecular optimization, and improve efficiency across multiple programs. Building on a 2024 partnership that created a generative AI foundation model, the initiative highlights Israel’s growing role in cutting-edge AI and biotech innovation. Google Cloud Israel’s Boaz Maoz called the project “a leap in autonomous discovery at global scale.”